Elliot Norry, Chief Medical Officer at Adaptimmune Therapeutics PLC (ADAP), sold 5,584 shares at $0.58 ($3K) on 2025-01-17, disclosed to the SEC on 2025-01-17.
Seasonal sale ($3k) by Chief Medical Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADAP | SELL | 2024-01-12 | $10K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $4K | — | Filing → |
| ADAP | SELL | 2023-01-12 | $19K | — | Filing → |